Approval · Notice of Compliance 25478 · 2021
RESPOTIL: Notice of Compliance 25478
Issued March 22, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25478
- Date
- March 22, 2021
- Company
- Modern Veterinary Therapeutics LlcSunrise, Florida, United States
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- PULMOTIL (Elanco Canada Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESPOTIL | 02513811 | Marketed |
Medicinal ingredients
- TILMICOSIN PHOSPHATE 250 MG per ML